ATONRA PARTNERS – Alnylam Pharmaceuticals, Inc. Transaction History
ATONRA PARTNERS portfolio value:
$1.20M
portfolio value
ATONRA PARTNERS quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.71% | -43 shares | 321K | $200.16 | 6.02K |
| Q2 2022 | share | Decrease | -36.62% | -3.50K shares | -678K | $145.85 | 6.07K |
| Q1 2022 | share | Increase | +1.58% | 149 shares | -35K | $163.29 | 9.58K |
| Q4 2021 | share | Increase | +8.61% | 748 shares | -41K | $171.03 | 9.43K |
| Q3 2021 | share | Increase | +7.25% | 587 shares | 267K | $188.81 | 8.68K |
| Q2 2021 | share | Decrease | -59.94% | -12.11K shares | -1.48M | $169.52 | 8.09K |
| Q1 2021 | share | Increase | +173.48% | 12.82K shares | 1.89M | $141.19 | 20.21K |
| Q4 2020 | share | Increase | 0.00% | 7.39K shares | 960K | $129.97 | 7.39K |